NasdaqGS - Delayed Quote USD
Editas Medicine, Inc. (EDIT)
1.9700
-0.2100
(-9.63%)
At close: June 13 at 4:00:01 PM EDT
2.0200
+0.05
+(2.54%)
After hours: June 13 at 7:25:13 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-208,211
-210,284
-132,178
-177,349
-163,803
Investing Cash Flow
223,278
162,146
-3,731
114,068
-54,466
Financing Cash Flow
54,398
56,027
118,039
1,284
282,106
End Cash Position
142,569
135,418
127,529
145,399
207,396
Capital Expenditure
-7,069
-8,826
-4,719
-4,118
-7,977
Issuance of Capital Stock
1,435
0
117,079
0
249,459
Free Cash Flow
-215,280
-219,110
-136,897
-181,467
-171,780
12/31/2021 - 2/3/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NTLA Intellia Therapeutics, Inc.
8.31
-0.48%
BEAM Beam Therapeutics Inc.
17.06
-2.18%
CRSP CRISPR Therapeutics AG
41.36
+0.19%
FATE Fate Therapeutics, Inc.
1.2750
-8.93%
SGMO Sangamo Therapeutics, Inc.
0.4910
-2.39%
PRME Prime Medicine, Inc.
1.4600
0.00%
VERV Verve Therapeutics, Inc.
6.16
-2.53%
CRBU Caribou Biosciences, Inc.
1.1100
-4.31%
DNA Ginkgo Bioworks Holdings, Inc.
8.94
-3.77%
SANA Sana Biotechnology, Inc.
2.5900
+1.97%